4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-032447
Chief Executive Officer sold 8,800 shares at an average $51.74 ($455,313)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2018-05-21 | Sale | −1,500 | $51.67 | $77,505 | 178,578 | I: show line 1 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2018-05-21 | Sale | −2,000 | $52.83 | $105,660 | 176,578 | I: show line 2 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2018-05-21 | Sale | −900 | $53.64 | $48,276 | 175,678 | I: show line 3 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2018-05-22 | Sale | −4,400 | $50.88 | $223,872 | 171,278 | I: show line 4 in the form |
| Open-market sales · 8,800 sh · avg $51.74 · $455,313 | |||||||
Loading xslF345X03/doc4.xml…